1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Tiziano Frateschi
Tiziano Frateschi
Articles (1511)  | Author's Website |

6 Stocks Beating the Market

Bio-Rad Laboratories tops list of stocks that have outperformed the S&P 500 Index

According to the GuruFocus All-in-One Guru Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the past 12 months and were bought by gurus during the last quarter.

Bio-Rad Laboratories Inc. (NYSE:BIO) has a market cap of $8.95 billion. It has outperformed the S&P 500 Index by 15.8% over the past 12 months.

The stock is trading with a price-book ratio of 2. According to the discounted cash flow calculator, the stock is overpriced by 11% at $301 per share. The stock price is currently 44.05% above its 52-week low and 0.19% below its 52-week high.

The company manufactures and supplies systems used to separate and analyze chemical and biological materials to life sciences and health care companies. It has a profitability and growth rating of 6 out of 10. Its return on equity of 24.28% and return on assets of 16.83% are outperforming 61% of other companies in the Global Diagnostics & Research industry. Its financial strength is rated 8 out of 10. The cash-debt ratio of 1.77 is below the industry median of 3.52.

The company’s largest shareholder among the gurus is Jim Simons (Trades, Portfolio) with 1.15% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.89% and John Rogers (Trades, Portfolio) with 0.84%.

With a market cap of $12.17 billion, Black Knight Inc. (NYSE:BKI) has outperformed the S&P 500 Index by 18.7% over the past 12 months.

The stock is trading with a price-book ratio of 4.75. According to the DCF calculator, the stock is overpriced by 209% at $51.95 per share. The stock price is currently 37.25% above its 52-week low and 1.98% below its 52- week high.

The company, which provides software, data and analytics solutions, has a profitability and growth rating of 6 out of 10. Its return on equity of 15.81% and return on assets of 5.75% are outperforming 60% of other companies in the Global Software – Infrastructure industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 0.01 is below the industry median of 8.37.

Daniel Loeb (Trades, Portfolio) is the largest shareholder of the company among the gurus with 0.84% of outstanding shares, followed by Columbia Wanger (Trades, Portfolio) with 0.29% and Simons with 0.19%.

BlackRock Inc. (NYSE:BLK) has a market cap of $88.47 billion. It has outperformed the S&P 500 Index by 17.2% over the past 12 months.

The stock is trading with a price-book ratio of 2.77. According to the DCF calculator, the stock is undervalued with a 24% margin of safety at $549.06 per share. The stock price is currently 34.37% above its 52-week low and 7.65% below its 52-week high.

The investment management company has a profitability and growth rating of 9 out of 10. While its return on equity of 17.03% is outperforming the sector, its return on assets of 2.35% is underperforming 57% of other companies in the Global Asset Management industry. Its financial strength is rated 5 out of 10 with a cash-debt ratio of 1.21.

The company’s largest guru shareholder is Loeb with 0.68% of outstanding shares, followed by Steve Mandel (Trades, Portfolio) with 0.57% and Pioneer Investments (Trades, Portfolio) with 0.28%.

With a market cap of $5.04 billion, Blackbaud Inc. (NASDAQ:BLKB) has outperformed the S&P 500 Index by 17.2% over the past 12 months.

The stock is trading with a price-book ratio of 14.63. According to the DCF calculator, the stock is overpriced by 547% at $103.81 per share. The stock price is currently 27.16% above its 52-week low and 10.56% below its 52-week high.

The company, which provides cloud software and other related services, has a profitability and growth rating of 8 out of 10. Its return on equity of 25.09% and return on assets of 5.37% are outperforming 60% of other companies in the Global Software - Application industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.05 is below the industry median of 8.37.

Simons is the company's largest guru shareholder with 0.41% of outstanding shares, followed by Pioneer Investments with 0.16% and Caxton Associates (Trades, Portfolio) with 0.01%.

Bluebird Bio Inc. (NASDAQ:BLUE) has a market cap of $9.02 billion. It has outperformed the S&P 500 Index by 44.2% over the past 12 months.

The stock is trading with a price-book ratio of 5.73. The stock price is currently 110.04% above its 52-week low and 23.83% below its 52-week high.

The company develops therapies for severe genetic and rare diseases. It has a profitability and growth rating of 2 out of 10. Its return on equity of -30.08% and return on assets of -24.80% are outperforming 56% of other companies in the Global Biotechnology industry. Its financial strength is rated 6 out of 10. The cash-debt ratio of 7.21 is below the industry median of 73.06.

With 0.65% of outstanding shares, the Vanguard Health Care Fund (Trades, Portfolio) has the largest position, followed by Simons with 0.2%, Steven Cohen (Trades, Portfolio) with 0.01% and Joel Greenblatt (Trades, Portfolio) with 0.01%.

With a market cap of $6.76 billion, BOK Financial Corp. (NASDAQ:BOKF) has outperformed the S&P 500 Index by 6.8% over the past 12 months.

The stock is trading with a price-book ratio of 1.94. According to the DCF calculator, the stock is overpriced by 77% at $103.3 per share. The stock price is currently 33.98% above its 52-week low and 3.46% below its 52-week high.

The bank holding company has a profitability and growth rating of 3 out of 10. Its return on equity of 10.10% and return on assets of 1.08% are outperforming 61% of other companies in the Global Banks - Regional - U.S. industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.44 is below the industry median of 2.12.

Diamond Hill Capital (Trades, Portfolio) is the company's largest guru shareholder with 1.24% of outstanding shares, followed by Rogers with 0.79%, Chuck Royce (Trades, Portfolio) with 0.75% and Columbia Wanger (Trades, Portfolio) with 0.38%.

Disclosure: I do not own any stocks mentioned in this article.

About the author:

Tiziano Frateschi
You can read about me on this blog: www.theextraincome.info

It gives suggestions on position trading.

Visit Tiziano Frateschi's Website


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Tiziano Frateschi


User Generated Screeners


mjspencerdiv incr no debt
ahmedhashim100Screen 6
aboer52AB Basic DN <6<6 Benish>-5 AZ<
y.dimitrovinsider buying
kazu2013-05-20 bu
DBrizancdn 18Jun2018 1213a
DBrizancdn 17Jun2018 1157p
DBrizancdn 17Jun2018 1155p
DBrizanAM SD17Jun2018 550p
ChabiCurt-small cap-100m-500m-EBITD
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK